1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Toke, O.
Banoczi, Z.
Kiraly, P.
Heinzmann, R.
Burck, J.
Ulrich, A.S.
Hudecz, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
GW
Eur.Biophys.J.
EBJOE8
0997
0175-7571
40
447
462
10.1007/s00249-010-0657-0
21234559
A kinked antimicrobial peptide from Bombina maxima. I. Three-dimensional structure determined by NMR in membrane-mimicking environments.
2011
2617.137
Antimicrobial peptide
UNP residues 44-70
1
syn
polymer
no
no
GIGGVLLSAGKAALKGLAKVLAEKYAN
GIGGVLLSAGKAALKGLAKVLAEKYAN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
1
0
2013-12-25
BMRB
Y
RCSB
2013-12-05
REL
REL
REL
161274
Giant fire-bellied toad, Chinese red belly toad
Bombina maxima
sample
structures with the lowest energy
100
10
2D 1H-1H TOCSY
2D 1H-1H NOESY
2D 1H-15N HSQC
2D 1H-13C HSQC
1-1.2
mM
10
mM
200
mM
[U-100% 2H]
220
5.0
ambient
313
K
torsion angle dynamics, simulated annealing
1
lowest energy
1-1.2 mM maximin, 10 mM sodium-phosphate, 200 mM [U-100% 2H] d25-sodium-dodecyl-sulfate, 90% H2O/10% D2O
90% H2O/10% D2O
Varian
collection
VNMRJ
Accelrys
peak picking
Felix
Accelrys
processing
Felix
Linge, O'Donoghue and Nilges
structure solution
ARIA
Linge, O'Donoghue and Nilges
refinement
ARIA
Linge, O'Donoghue and Nilges
geometry optimization
ARIA
600
Varian
Varian NMR System
Varian Varian NMR System
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
GLY
3
n
3
GLY
3
A
GLY
4
n
4
GLY
4
A
VAL
5
n
5
VAL
5
A
LEU
6
n
6
LEU
6
A
LEU
7
n
7
LEU
7
A
SER
8
n
8
SER
8
A
ALA
9
n
9
ALA
9
A
GLY
10
n
10
GLY
10
A
LYS
11
n
11
LYS
11
A
ALA
12
n
12
ALA
12
A
ALA
13
n
13
ALA
13
A
LEU
14
n
14
LEU
14
A
LYS
15
n
15
LYS
15
A
GLY
16
n
16
GLY
16
A
LEU
17
n
17
LEU
17
A
ALA
18
n
18
ALA
18
A
LYS
19
n
19
LYS
19
A
VAL
20
n
20
VAL
20
A
LEU
21
n
21
LEU
21
A
ALA
22
n
22
ALA
22
A
GLU
23
n
23
GLU
23
A
LYS
24
n
24
LYS
24
A
TYR
25
n
25
TYR
25
A
ALA
26
n
26
ALA
26
A
ASN
27
n
27
ASN
27
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
HA
HB1
ALA
ALA
22
26
1.12
1
A
A
HG22
HD13
VAL
LEU
5
6
1.28
2
A
A
HA
HB1
ALA
ALA
22
26
1.17
2
A
A
HG21
HD12
VAL
LEU
5
6
1.30
3
A
A
HA
HB3
ALA
ALA
22
26
1.13
3
A
A
HG21
HD13
VAL
LEU
5
6
1.29
4
A
A
HA
HB1
ALA
ALA
22
26
1.16
4
A
A
H
H
LEU
LEU
6
7
1.33
5
A
A
HA
HB3
ALA
ALA
22
26
1.21
5
A
A
HG21
HD13
VAL
LEU
5
6
1.31
6
A
A
HA
HB3
ALA
ALA
22
26
1.29
7
A
A
HA
HB3
ALA
ALA
22
26
1.17
7
A
A
HG22
HD11
VAL
LEU
5
6
1.35
8
A
A
HA
HB1
ALA
ALA
22
26
1.21
8
A
A
HA
HB2
ALA
LEU
18
21
1.30
9
A
A
HA
HB2
ALA
ALA
22
26
1.13
9
A
A
HG21
HD12
VAL
LEU
5
6
1.27
9
A
A
HA
HB2
ALA
LEU
18
21
1.33
10
A
A
HA
HB2
ALA
ALA
22
26
1.17
10
A
A
HG22
HD11
VAL
LEU
5
6
1.28
1
-3.75
0.60
121.00
117.25
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
2
-3.73
0.60
121.00
117.27
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
3
-3.67
0.60
121.00
117.33
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
5
-3.61
0.60
121.00
117.39
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
6
-3.80
0.60
121.00
117.20
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
7
-3.79
0.60
121.00
117.21
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
8
-3.75
0.60
121.00
117.25
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
9
-3.69
0.60
121.00
117.31
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
10
-3.79
0.60
121.00
117.21
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
1
A
ILE
2
-118.83
-77.60
1
A
LEU
6
176.25
-22.16
1
A
LEU
7
-65.06
-77.04
1
A
LYS
15
-92.77
-69.96
1
A
LEU
17
-59.96
-8.11
2
A
ILE
2
-104.86
-74.05
2
A
LEU
6
178.13
-22.37
2
A
LEU
7
-63.01
-78.38
2
A
LYS
15
-86.10
-72.09
3
A
ILE
2
-116.27
-81.53
3
A
LEU
6
-179.87
-22.14
3
A
LEU
7
-64.91
-79.07
3
A
LYS
15
-94.74
-69.28
4
A
ILE
2
-100.74
-79.61
4
A
LEU
6
-166.50
-16.45
4
A
LYS
15
-95.22
-69.60
5
A
ILE
2
-103.11
-61.11
5
A
VAL
5
-141.81
-59.49
5
A
LEU
6
-171.82
-17.88
5
A
LYS
15
-92.56
-70.27
6
A
ILE
2
-116.38
-76.26
6
A
LEU
6
-175.42
-23.34
6
A
LEU
7
-62.44
-77.09
6
A
LYS
15
-96.05
-70.89
7
A
ILE
2
-130.87
-74.73
7
A
LEU
6
-176.41
-22.91
7
A
LEU
7
-65.18
-76.74
7
A
LYS
15
-95.38
-72.25
8
A
ILE
2
-103.72
-75.89
8
A
LEU
6
-178.03
-23.02
8
A
LEU
7
-63.92
-74.58
8
A
LYS
15
-95.46
-70.61
8
A
LEU
17
-58.40
-2.07
9
A
ILE
2
-105.74
-79.13
9
A
LEU
6
178.40
-20.85
9
A
LYS
15
-95.08
-69.57
9
A
LEU
17
-59.61
-2.68
10
A
ILE
2
-95.07
-77.06
10
A
LEU
6
173.84
-22.27
10
A
LEU
7
-64.08
-74.70
10
A
LYS
15
-92.81
-70.56
Antimicrobial peptide
lowest energy, model1
The solution NMR structure of maximin-4 in SDS micelles
1
N
N
A
LEU
7
A
LEU
7
HELX_P
A
GLY
16
A
GLY
16
1
1
10
A
LEU
17
A
LEU
17
HELX_P
A
TYR
25
A
TYR
25
1
2
9
ANTIMICROBIAL PROTEIN, MEMBRANE PROTEIN
membrane peptides, lipid bilayers, bacterial resistance, antimicrobial peptides, ANTIMICROBIAL PROTEIN, MEMBRANE PROTEIN
C3RSY7_BOMMX
UNP
1
44
C3RSY7
GIGGVLLSAGKAALKGLAKVLAEKYAN
44
70
2MHW
1
27
C3RSY7
A
1
1
27